Author:
Nakayita Renniter Mirembe,Benyumiza Deo,Nekesa Catherine,Misuk Ivan,Kyeswa Julius,Nalubuuka Aisha,Murungi Tom,Udho Samson,Kumakech Edward
Abstract
Abstract
Background
Cervical cancer is the most common Human Papilloma Virus (HPV)-related disease among women. Since 2008, HPV vaccination has been routinely recommended for pre-adolescent and adolescent girls in Uganda as the primary preventive measure for cervical cancer. However, in Uganda, most especially in Lira district, there is limited literature on HPV vaccination uptake and associated factors among girls aged 9-14years. This study assessed the uptake of HPV vaccine and associated factors among in-school girls aged 9–14 years in Lira City, northern Uganda.
Methods
A cross-sectional study was conducted among 245 primary school girls aged 9–14 years in Lira City, northern Uganda. Multistage sampling technique was used to sample eligible participants and data was collected using interviewer administered questionnaire. Data was analysed using SPSS version 23.0. Descriptive statistics and multivariate logistic regression at 95% level of significance were used to identify the level of HPV vaccine uptake and predictors respectively.
Results
HPV vaccination uptake was at 19.6% (95% CI,14.8–25.1) among the school girls aged 9–14 years in Lira City, northern Uganda. The mean age of the girls was 12.11 (± 1.651) years. Predictors that were independently associated with HPV vaccine uptake included; recommendation from health worker [aOR 9.09, 95% CI (3.19–25.88), P ≤ 0.001], taught about cervical cancer at school [aOR,12.56, 95% CI (4.60–34.28), P ≤ 0.001], and exposure to outreach clinics [aOR, 4.41, 95% CI (1.37–14.19), P = 0.013].
Conclusion
The study found that one in five of the school girls in Lira City, northern Uganda. received HPV vaccine. Girls who were taught about cervical cancer at school, exposure to outreach clinics and received health worker recommendation had more odds of receiving HPV vaccine than their counter parts. The Ministry of Health should strengthen school based cervical cancer education, awareness raising about HPV vaccination and health worker recommendations to improve HPV vaccine uptake among school girls in Uganda.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference33 articles.
1. Mayoral E, Mayoral-Andrade G, ? LMA of M, 2018 undefined. Diagnosis of Transient/Latent HPV Infections-A Point of View! Elsevier.
2. Medicines IBJ. of B and, 2018 undefined. Human Papillomavirus—The Cause of Human Cervical Cancer. scirp.org.
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–49.
4. Spayne J, Hesketh T. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators. BMJ Open [Internet]. 2021 Sep 1 [cited 2022 Oct 31];11(9):e052016. Available from: https://bmjopen.bmj.com/content/11/9/e052016.
5. Bruni L, Saura-Lázaro A, Montoliu A, Brotons M, Alemany L, Diallo MS et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med (Baltim) [Internet]. 2021 Mar 1 [cited 2023 Mar 24];144. Available from: https://pubmed.ncbi.nlm.nih.gov/33388322/.